RT Journal Article
SR Electronic
T1 Detection of Chikungunya virus in The Gambia through a newly implemented sentinel surveillance program
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.11.24303694
DO 10.1101/2024.03.11.24303694
A1 Diallo, Amadou Woury
A1 Dieng, Idrissa
A1 Sanneh, Bakary
A1 Barry, Mamadou Aliou
A1 Talla, Cheikh
A1 Sanneh, Modou Lamin
A1 Sagne, Samba Niang
A1 Cisse, Mamadou
A1 Mendy, Alphonse
A1 Kijera, Muhammed
A1 York, Karamo
A1 Faal, Alieu
A1 Sey, Alhagie Papa
A1 Jallow, Ebrima K.
A1 Manneh, Lamin
A1 Darboe, Sheriffo M.K.
A1 Jatta, Balla
A1 Kalisa, Momodou
A1 Sanneh, Adama M.B.
A1 Njie, Modou
A1 Nyassi, Momodou T.
A1 Bittaye, Mustapha
A1 Dia, Ndongo
A1 Sall, Amadou Alpha
A1 Faye, Ousmane
A1 Diagne, Moussa Moise
A1 Faye, Oumar
A1 Diallo, Boubacar
A1 Jagne, Sheriffo
A1 Sow, Abdourahmane
YR 2024
UL http://medrxiv.org/content/early/2024/03/11/2024.03.11.24303694.abstract
AB We characterized 01 autochthonous chikungunya virus (CHIKV) case from (The Gambia) through a newly implemented local arboviruses surveillance program in the, highlighting the first notification of the virus in the Country. Identified virus is closely related to CHIKV West African genotype detected in Kédougou (Senegal) in 2023 and responsible of a large outbreak with up to 300 confirmed cases. This work describes the first genomic proof subregional spread of CHIKV West African genotype in West Africa.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Africa CDCAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Gambian National Ethical Committee of the Ministry of Health and Social Welfare approved the surveillance protocol which led to the obtention of human sera as less than minimal risk research, and written consent were not required. Throughout the study, the database was shared with the Service Ministry of Health and Social Welfare of the Gambia for appropriate public health action.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors